派林生物,000403,收入构成,报告日期,2021-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,79046,42354,36691,46.42%,100% 其他,16,-- ,-- ,--,0% 派林生物,000403,收入构成,报告日期,2020-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,104250,53736,50514,48.45%,100% 其他,744,-- ,-- ,--,0% 派林生物,000403,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),12,-- ,-- ,--,0% 血液制品,42701,22580,20122,47.12%,100% 派林生物,000403,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),769,-- ,-- ,--,0% 血液制品,90797,43641,47156,51.94%,100% 派林生物,000403,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),480,-- ,-- ,--,0% 血液制品,39700,18975,20725,52.2%,100% 派林生物,000403,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1236,1,1236,99.95%,2.69% 血液制品,84749,40129,44620,52.65%,97.31% 其他,1231,-- ,-- ,--,0% 细胞培养基,4,-- ,-- ,--,0% 派林生物,000403,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 细胞培养基,4,4,1,14.77%,0% 血液制品,42652,19942,22710,53.25%,100% 派林生物,000403,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 血液制品,68509,29474,39036,56.98%,99.95% 细胞培养基,28,11,18,62.69%,0.05% 派林生物,000403,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),382,-- ,-- ,--,0% 血液制品,31757,12550,19207,60.48%,100% 派林生物,000403,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,137,-- ,-- ,--,0% 血液制品,56606,24957,31650,55.91%,100% 派林生物,000403,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),137,-- ,-- ,--,0% 血液制品,28108,13309,14800,52.65%,100% 派林生物,000403,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),486,1,485,99.79%,1.83% 膏药敷料,513,1083,-569,-110.82%,-2.15% 血液制品,49028,22460,26568,54.19%,100.32% 派林生物,000403,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 破免,366,210,156,42.56%,1.28% 其他(补充),105,-- ,-- ,--,0% 2.5G静注人免疫球蛋白,7361,4290,3072,41.73%,25.24% 狂免,3964,1816,2148,54.19%,17.65% 5G人血白蛋白,2111,1082,1028,48.72%,8.45% 10G人血白蛋白,11620,5853,5767,49.63%,47.39% 派林生物,000403,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 膏药敷料,548,309,239,43.57%,0.85% 血液制品,48170,20692,27478,57.04%,98.33% 其他(补充),232,3,228,98.6%,0.82% 派林生物,000403,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1,-- ,-- ,--,0% 膏药、敷料,548,309,239,43.57%,2.51% 血液制品,15274,6013,9261,60.63%,97.49% 派林生物,000403,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),695,-- ,-- ,--,0% 膏药敷料,3749,1783,1966,52.44%,7.02% 血液制品,43328,17277,26051,60.13%,92.98% 派林生物,000403,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),227,-- ,-- ,--,0% 膏药、敷料,1771,849,922,52.07%,6.24% 血液制品,22274,8411,13863,62.24%,93.76% 派林生物,000403,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),273,-- ,-- ,--,0% 膏药、敷料,3628,1710,1918,52.86%,6.65% 血液制品,43082,16165,26917,62.48%,93.35% 派林生物,000403,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),90,-- ,-- ,--,0% 麝香追风膏,224,142,82,36.79%,0.59% 狂犬人免疫球蛋白,3553,1065,2488,70.02%,17.75% 人血白蛋白,10181,4162,6019,59.12%,42.95% 静注人免疫球蛋白,7658,2895,4763,62.2%,33.98% 田七镇痛膏,779,194,585,75.06%,4.17% 麝香壮骨膏,206,128,78,37.92%,0.56% 派林生物,000403,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 乙免,1208,257,951,78.76%,3.49% 特免,8333,1973,6360,76.32%,23.33% 人免疫球蛋白,1018,526,492,48.29%,1.8% 静注人免疫球蛋白,13848,4525,9323,67.33%,34.2% 人血白蛋白,17129,6995,10134,59.16%,37.18% 其他(补充),233,-- ,-- ,--,0% 派林生物,000403,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),138,2,136,98.27%,0.99% 田七镇痛膏,786,194,592,75.27%,4.31% 麝香追风膏,289,175,114,39.59%,0.83% 麝香壮骨膏,238,151,87,36.68%,0.64% 狂犬人免疫球蛋白,4392,983,3408,77.61%,24.82% 静注人免疫球蛋白,5195,1546,3649,70.23%,26.57% 人血白蛋白,9702,3957,5745,59.22%,41.84% 派林生物,000403,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),338,6,333,98.35%,1.31% 乙免,848,117,731,86.2%,2.88% 狂免,9703,1382,8321,85.76%,32.81% 静注人免疫球蛋白,8666,1652,7014,80.94%,27.65% 人血白蛋白,16369,7405,8964,54.76%,35.34% 派林生物,000403,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 田七镇痛膏,647,162,485,74.97%,3.35% 麝香追风膏,226,147,79,35.11%,0.55% 麝香壮骨膏,186,112,73,39.49%,0.51% 硫酸双氢链霉素,1023,1263,-240,-23.47%,-1.66% 板式组合药,1039,528,511,49.2%,3.54% 硫酸链霉素,1066,1204,-138,-13%,-0.96% 新霉素原粉,2845,3051,-206,-7.23%,-1.42% 狂犬人免疫球蛋白,5359,699,4660,86.95%,32.23% 静注人免疫球蛋白,5323,897,4426,83.15%,30.61% 人血白蛋白,8557,3749,4808,56.19%,33.25% 派林生物,000403,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 电力,1136,1179,-43,-3.78%,-0.23% 田七镇痛膏,1715,464,1251,72.95%,6.58% 麝香追风膏,736,458,279,37.86%,1.47% 麝香壮骨膏,565,369,196,34.66%,1.03% 板式组合药,3124,1540,1584,50.72%,8.34% 硫酸链霉素,2295,2561,-265,-11.57%,-1.4% 硫酸双氢链霉素,3476,3669,-192,-5.53%,-1.01% 狂犬人免疫球蛋白,5161,802,4360,84.47%,22.94% 静注人免疫球蛋白,6337,1038,5300,83.63%,27.88% 人血白蛋白,11759,5221,6538,55.6%,34.4% 派林生物,000403,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 田七镇痛膏,750,201,549,73.19%,8.98% 麝香追风膏,283,176,107,37.89%,1.75% 麝香壮骨膏,197,127,70,35.66%,1.15% 板式组合药,1595,773,822,51.54%,13.45% 硫酸链霉素,1310,1668,-358,-27.35%,-5.86% 硫酸双氢链霉素,1311,1321,-10,-0.79%,-0.17% 狂犬人免疫球蛋白,1540,322,1218,79.09%,19.92% 静注人免疫球蛋白,1852,334,1518,81.96%,24.83% 人血白蛋白,4887,2608,2279,46.64%,37.28% 电力,1136,1218,-82,-7.2%,-1.34% 派林生物,000403,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 电力,6040,6099,-59,-0.98%,-0.58% 机械制造,3399,2082,1317,38.76%,12.8% 制药,24166,15133,9033,37.38%,87.77% 派林生物,000403,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其它,417,395,22,5.16%,0.13% 电力,12191,11940,251,2.06%,1.54% 机械制造,4929,4608,321,6.52%,1.97% 制药,46966,31224,15742,33.52%,96.36% 派林生物,000403,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 板式组合药,2995,1649,1345,44.92%,34.89% 利福喷丁胶囊,429,148,282,65.61%,7.3% 头孢粉针系列,222,229,-7,-2.98%,-0.17% 硫酸双氢链霉素,2304,1862,443,19.21%,11.48% 新霉素原粉,2554,2550,4,0.16%,0.11% 硫酸链霉素,1447,1430,17,1.16%,0.44% 土霉素碱,1961,2389,-428,-21.8%,-11.09% 环保车辆及配套设备,1703,1331,372,21.86%,9.66% 装载机及配件,984,1444,-460,-46.71%,-11.92% 人免疫球蛋白(含其他),919,328,591,64.31%,15.34% 人血白蛋白,2219,1613,606,27.31%,15.72% 外敷药,1528,737,791,51.76%,20.51% 电力,6230,5931,299,4.8%,7.76% 派林生物,000403,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 2.5G静注人免疫球蛋白,129,61,68,52.58%,-9.86% 人血白蛋白,72,71,1,0.96%,-0.1% 板式组合药,2441,1397,1044,42.79%,-151.38% 硫酸新霉素,730,4361,-3631,-497.26%,526.27% 电力,9971,8218,1752,17.57%,-253.97% 轮式装载机,10001,9925,76,0.76%,-10.96% 派林生物,000403,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 XGL30装载机,6048,6429,-381,-6.3%,-24.56% 煤电,6552,5199,1352,20.64%,87.2% 新霉素原料,3280,2701,579,17.67%,37.37% 派林生物,000403,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 电力供应,3426,2620,806,23.53%,72.35% 装载机,3833,3525,308,8.04%,27.65% 派林生物,000403,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 电力,7021,6219,802,11.42%,5.82% 医务用品,3488,1610,1878,53.83%,13.63% 环保车,2747,2192,555,20.2%,4.03% 机械设备,28943,25015,3929,13.57%,28.53% 机修,288,253,35,12.01%,0.25% 药机,148,82,66,44.4%,0.48% 药品销售,31660,25152,6508,20.56%,47.26% 派林生物,000403,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 电,3461,2236,1225,35.4%,18.21% 新霉素原粉,5586,3933,1653,29.6%,24.57% 装载机,25462,21611,3851,15.13%,57.23% 派林生物,000403,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药业双氢,1245,948,297,23.87%,6.79% 新霉素原粉,3508,2446,1062,30.26%,24.24% 装载机,20105,17085,3020,15.02%,68.97% 派林生物,000403,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 XGL50装载机,1892,1581,310,16.4%,27.21% XGL30装载机,4013,3562,450,11.22%,39.5% 硫酸新霉素,1257,878,379,30.19%,33.29% 派林生物,000403,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药品制造,27377,20683,6695,24.45%,49.74% 血液制品,6119,4521,1599,26.13%,11.88% 装载机,33484,28319,5165,15.43%,38.38% 派林生物,000403,收入构成,报告日期,2004-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 人血白蛋白,4664,3398,1266,27.14%,36.99% ZL50B装载机,6714,5484,1230,18.32%,35.95% XGL30装载机,8668,7742,926,10.68%,27.05% 派林生物,000403,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 ZL50B装载机,5147,4204,944,18.33%,34.27% XGL30装载机,8668,7742,926,10.68%,33.62% 人血白蛋白(10克),3688,2804,884,23.97%,32.11% 派林生物,000403,收入构成,报告日期,2004-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 ZL50B装载机,2763,2260,504,18.22%,36.48% XGL30装载机,5101,4571,529,10.38%,38.35% 人血白蛋白(10g),2016,1668,347,17.24%,25.17% 派林生物,000403,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 ZL50B装载机,7412,6173,1239,16.71%,34.35% XGL30装载机,10537,9426,1111,10.55%,30.82% 人血白蛋白(10g),6651,5396,1256,18.88%,34.82% 派林生物,000403,收入构成,报告日期,2003-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 人血白蛋白(10g),4961,3692,1269,25.58%,32.17% ZL50B装载机,5265,4420,845,16.06%,21.43% XGL30装载机,8207,7330,876,10.68%,22.22% ZL30C装载机,4675,3722,953,20.39%,24.17% 派林生物,000403,收入构成,报告日期,2003-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 胸腺肽(20mg/2ml),946,195,751,79.37%,22.43% 人血白蛋白(10g),3183,2487,696,21.86%,20.79% ZL50B装载机,3284,2773,511,15.56%,15.26% ZL30C装载机,3342,2662,681,20.36%,20.33% 化清剂,2068,1359,709,34.3%,21.19% 派林生物,000403,收入构成,报告日期,2003-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:关联交易金额,1745,1339,407,23.31%,17.97% ZL50B装载机,1222,1045,177,14.48%,7.82% XGL30装载机,1477,1307,171,11.54%,7.53% ZL30D装载机,1283,1040,242,18.88%,10.7% ZL30C装载机,1457,1163,293,20.13%,12.96% 人血白蛋白(10g),1661,1271,390,23.47%,17.22% 化清剂,1656,1072,584,35.27%,25.81% 派林生物,000403,收入构成,报告日期,2001-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 工程机械,7213,0,7213,100%,31.42% 精细化工,12714,0,12714,100%,55.38% 生物制药,3031,0,3031,100%,13.2%